SurModics
SRDX
$32.09
Share price
2.82%
Change (1 day)
-7.65%
Change (1 year)
Categories
Market capitalization of SurModics (SRDX)
Market cap: $0.45 Billion
As of September 2023 SurModics has a market cap of $0.45 Billion. This makes SurModics the world's 5803th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of SurModics from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $0.45 B | -5.9% |
| 2022 | $0.48 B | -28.37% |
| 2021 | $0.67 B | 13.01% |
| 2020 | $0.59 B | 5.73% |
| 2019 | $0.56 B | -11.61% |
| 2018 | $0.63 B | 72.45% |
| 2017 | $0.36 B | 9.66% |
| 2016 | $0.33 B | 27.9% |
| 2015 | $0.26 B | -7.87% |
| 2014 | $0.28 B | -13.94% |
| 2013 | $0.33 B | 1.34% |
| 2012 | $0.32 B | 27.59% |
| 2011 | $0.25 B | 23.78% |
| 2010 | $0.20 B | -47.57% |
| 2009 | $0.39 B | -11.31% |
| 2008 | $0.44 B | -54.98% |
| 2007 | $0.99 B | 73.25% |
| 2006 | $0.57 B | -16.59% |
| 2005 | $0.68 B | 19.84% |
| 2004 | $0.57 B | 38.11% |
| 2003 | $0.41 B | -16.42% |
| 2002 | $0.49 B | -18.94% |
| 2001 | $0.61 B |
End of Day market cap according to different sources
On Sep 29th, 2023 the market cap of SurModics was reported to be:
$0.45 Billion
$0.45 Billion
$0.45 Billion
$0.45 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $375.59 B | 82,710.94% | 🇺🇸 USA |
 Abbott Laboratories ABT | $168.06 B | 36,955.65% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $195.35 B | 42,971.77% | 🇺🇸 USA |
 Agilent Technologies A | $32.71 B | 7,113.39% | 🇺🇸 USA |
 PerkinElmer
PKI | $14.45 B | 3,087.19% | 🇺🇸 USA |
 Alkermes ALKS | $4.66 B | 928.60% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.11 B | -75.03% | 🇺🇸 USA |
 Heron Therapeutics HRTX | $0.14 B | -68.03% | 🇺🇸 USA |
 Enzo Biochem ENZ | $70.49 M | -84.46% | 🇺🇸 USA |